GleamWall
中文EN

ALEC Alector, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1653087 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY151.1%
TTM net income YoY138.4%
TTM EPS YoY134.0%
Revenue 3-yr CAGR21.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin20.2%
Net margin23.9%
FCF margin-86.5%
EBITDA margin22.6%

Returns

ROE47.5%
ROA16.5%
ROIC (approx.)217.2%
Asset turnover0.69x

Leverage & solvency

Liabilities / assets29.7%
Debt / equity0.00x
Current ratio4.10x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-3.62x
Accruals ratio76.4%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$21.05M$100.56M
R&D expense$123.06M$185.94M
SG&A expense$53.99M$59.62M
Operating income-$156.01M-$145.00M
Pretax income-$142.76M-$118.92M
Income tax$168,000$128,000
Net income-$142.93M-$119.05M
EBITDA-$150.29M-$139.59M
EPS (basic)-1.39-1.23
EPS (diluted)-1.39-1.23
Weighted avg. shares (diluted)103.00M96.59M
Balance sheet
Cash & equivalents$65.80M$34.87M
Short-term investments$190.22M$380.38M
Current assets$266.45M$424.82M
PP&E, net$10.84M$17.14M
Total assets$293.24M$468.30M
Current liabilities$69.50M$125.06M
Short-term debt$366,000$0
Long-term debt$9.32M$9.39M
Total debt$9.69M$9.39M
Total liabilities$262.59M$341.50M
Shareholders' equity$30.65M$126.80M
Net debt-$56.11M-$25.48M
Shares outstanding110.36M99.09M
Cash flow statement
Operating cash flow-$184.03M-$229.91M
Capital expenditure$41,000$1.25M
Free cash flow-$184.07M-$231.16M
Investing cash flow$196.60M$107.13M
Financing cash flow$20.21M$81.54M
Depreciation & amortization$5.72M$5.41M
Stock-based compensation$26.66M$39.46M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.